DXCM EQUITY Surgical & Medical Instruments & Apparatus 2027 Quantitative Forecast

DexCom, Inc. (DXCM) Stock Price Prediction 2027

Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation

$79.32
$-0.87 (-1.08%)
Market Close: Nov 20, 2026
1-Year Base Target
$79.40 +0.1%
Constant-P/E algorithmic trajectory
Wall St. Consensus
$98.58 Bull $108
Institutional analyst mean target
Risk-Adjusted Consensus Fair Value
$83.79 +5.6% Undervalued
Forward P/E 25.3x • PEG 1.30
AI Quant Stance
HOLD 51/100
RSI 43.9 • MACD Bullish • Downtrend

Executive Forecast Synopsis (2027)

Synthesized fundamental, multiple & technical thesis for DXCM

AI Research Note

DXCM Price Forecast 2027: Our AI models project that DXCM stock will rise to approximately $79.40 by 2027. This represents a potential 0.1% growth from the current trading price of $79.32. The overall market sentiment for DXCM is currently neutral, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading at a P/E ratio of 31.6, with its most recent quarterly earnings growing by 2.6%. DXCM shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 43.9, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

Quant Signal & Technical Posture

Composite equity rating reconciled with 1-year target trajectory

Score: 50.5/100
Composite Equity Stance
HOLD (Quant Score 50/100) — HOLD
Active Technical & Price Action Triggers
  • Price consolidating in 4.38% range for 10 days
  • Moving averages converging - equilibrium state
  • MACD bullish crossover - upward momentum
  • Recent pattern: 3Outside pattern detected
  • Price near support at $79.78
MACD Regime: Bullish
Volume Tape: Neutral

DXCM Trajectory & Forecast Curve

Projected price curve from spot ($79.32) across 30D–3Y horizons

Term Structure of Price Targets

Constant-multiple earnings trajectory model

30D – 3Y
Horizon Target Price Implied Return
30 Days Near-Term $79.33 +0.0%
90 Days 1 Quarter $79.34 +0.0%
6 Months Medium-Term $79.36 +0.1%
1 Year Base Model $79.40 +0.1%
2 Years EXTENDED $79.48 +0.2%
3 Years EXTENDED $79.56 +0.3%
Wall Street 12M Consensus Target: $98.58

1-Year Scenario Distribution (Bull / Base / Bear)

Probability-weighted regime outcomes around the 12-month forecast horizon

Regime Matrix
Bull Case 30% Prob
$108.43 +36.7%

Best case scenario if strong fundamentals and market conditions align

Base Case 50% Prob
$79.40 +0.1%

Expected scenario based on current growth trajectory

Bear Case 20% Prob
$55.58 -29.9%

Downside scenario if market headwinds or disappointing results

LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $81.61 · IV 39.6%

DXCM Path Scenario ($79 Target): Simulated 5-Day Swing & LEAP Payoffs

Compare $8,161 for 100 DXCM shares against risk-defined 5-day option spreads and long-dated LEAP structures.

5-DAY BULLISH SWING Liq B

Dec 18 $80 / $90 Bull Call Spread

Buy 1x $80C · Sell 1x $90C · 31d

Net Entry $482 Debit
T+5d @ +5% Move +$136 (+28%)
Max Risk / Buffer $482 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $75 / $70 Bull Put Spread

Sell 1x $75P · Buy 1x $70P · 31d

Net Entry $86 Credit
Max Credit / Yield +$86 (+20.8% RoM)
Max Risk / Buffer -9.2% Cushion ($414 Mgn)
5d Edge & Liquidity 78% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $85 / $75 Bear Put Spread

Buy 1x $85P · Sell 1x $75P · 31d

Net Entry $380 Debit
T+5d @ -5% Drop +$186 (+49%)
Max Risk / Buffer $380 Capped
5d Edge & Liquidity 1.0x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Reverse-DCF Implied Growth, Supply-Chain Moat & R&D Velocity

Proprietary deep-tech expectations gap, supply-chain bottleneck scoring & patent/filing velocity

Deep-Tech & Valuation Intelligence
Supply-Chain Moat & Nx Model Bottleneck 7/10
Moat: Oligopoly • Position: Wearables Remote Monitoring (CGM)
1Y Modeled
1.03x
3Y Modeled
1.08x
5Y Thesis Adj
1.09x

Fair Value & Core Fundamentals

PEG-adjusted intrinsic valuation & balance-sheet multiples

+5.6% Undervalued
Risk-Adjusted Consensus Fair Value: $83.79
Spot: $79.32

Risk-Adjusted Consensus Fair Value (85% of Wall Street target) indicates DXCM trades at a discount to its forward earnings growth trajectory (5.6% implied margin of safety).

PEG Ratio
1.30
Fairly Valued
Implied Fair P/E
26.7x
Model Growth 24.3%
Trailing P/E
31.57x
Forward P/E
25.30x
P/S Ratio (TTM)
5.86x
Rev Growth (YoY)
11.2%
EPS Growth (YoY)
2.6%
Market Cap
$29,907M
52-Week High
$92.59
52-Week Low
$56.72

Technicals & Institutional Money Flow

Momentum oscillators, volume accumulation & key price levels

Neutral
Volume Tape: Neutral

Volume-weighted price action shows near-term supply/distribution pressure; watch support levels for stabilization.

RSI (14-Day)
43.9
Neutral
MACD Signal
Bullish
Primary Trend
Downtrend
Chaikin Money Flow
0.046
Money Flow Index
38.1
200-Day SMA
$88.14

Options Volatility Valuation: 1-Year Target Strike Strategy

Comparing LEAP Call Implied Volatility & Breakeven against the 1-Year Model Target — Derivative Strategy Signal, NOT an Equity Stock Rating

Options Strategy Only Strategy Score: 0/100
OPTIONS STRATEGY: OVERWRITING / CREDIT SPREADS
SELL COVERED CALLS / COLLECT PREMIUM (Options Overpriced vs. Target)
This is an Options Volatility Valuation signal (comparing Call IV to 1Y target), NOT a sell rating on DXCM shares.
Rich Call Premium (Write / Overwrite)
Premium Collected
$16.00/sh
Profit at 1Y Target
$16.00/sh
Option Writer ROI
+100.0%
Applicable Structures
Covered Call (safest) • Naked Call (risky) • Credit Spread (defined risk)
Why Options Are Flagged for Premium Selling: The $85 Call (Sep 2027) requires DXCM to exceed $101.00 at expiration just to break even. Because the conservative constant-P/E 1Y model target is $79.40, buying out-of-the-money calls carries negative expected value (Buyers lose 100.0% even if target hits. Premium is overpriced for 0.1% move.), whereas shareholders overwriting covered calls capture rich implied volatility.
1Y Constant-PE Target
$79.40
+0.1% vs spot
Evaluated Call Strike
$85.00
Exp: Sep 17, 2027
Call Mark Premium
$16.00
20.2% of spot price
Call Buyer Breakeven
$101.00
Above 1Y base target
Delta / Implied Prob
55.0%
Option market odds
Contract Liquidity
11 OI
Vol: 1 • Nov 20

Unusual Options Flow Alert (Short-Term Derivative Tape)

Short-term institutional sweep & implied volatility anomaly monitor (distinct from long-term equity rating)

Moderate Alert (Options Flow)
Flow Alert Score
79/100
Tape Classification
Moderate Alert (Options Flow)
Unusual Volume Score
69.2
Implied Volatility Spike
+160.6%
Derivative Tape Readout: Short-Term Derivative Tape: Moderate unusual activity. Monitor closely. (Reflects options volume & IV anomalies, not a long-term stock rating.)

Frequently Asked Questions (DXCM 2027 Outlook)

What is the DXCM stock price prediction for 2027?

Based on our AI analysis, DXCM is predicted to reach $79.40 by 2027, representing a potential 0.1% increase from the current price of $79.32.

Is DXCM stock a good buy right now?

Our analysis rates DXCM as a HOLD (AI Quant Score 50.5/100) based on current technical and fundamental indicators. With a projected 0.1% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.

What is DXCM 52-week high and low?

DXCM has a 52-week high of $92.59 and a 52-week low of $56.72. The stock is currently trading 14.3% below its 52-week high.

What is the technical analysis for DXCM?

DXCM is currently in a downtrend trend. The RSI of 43.9 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Where will DXCM stock be in 3 years?

Our long-term projection estimates DXCM could reach $79.56 by 2029, representing a 0.3% gain from current levels. Long-term predictions carry more uncertainty.

Quantitative Research Disclaimer: Price predictions, reverse-DCF expectations, and options volatility strategies are generated algorithmically from historical financial data, analyst consensus estimates, and live options chains. They are provided strictly for informational and research purposes and do not constitute investment advice. Always conduct independent due diligence before executing equity or derivative transactions.